Brightmeds vs He & She MD
An in-depth comparison of two leading GLP-1 Providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Brightmeds
Best for: knowing which pharmacy fills the vial — it names Beaker Pharmacy
Visit Brightmeds →
He & She MD
Best for: starting below a standard dose, with microdose tiers
Visit He & She MD →Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, He & She MD opens cheaper — $99/mo against $100, and He & She MD finishes ahead, 9.3 to 8.4. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.
Pricing
Brightmeds
'Starting at $189' is the only published sema price (1-month plan per on-page comparison chart); ongoing/renewal price NOT published anywhere on public pages as of 2026-07-14 — the '$333/mo therafter' card verified 2026-06-06 has been removed. 'Save $50 on our First Order' banner active.
'Starting at $289' shown on the sema lander card and in the tirz lander's pricing-comparison image ('Tirzepatide (1-Month) $289 — Best Price! 1-Month Plan'); the tirz lander TEXT now contains no dollar prices at all — both the old '$249/mo' hero and '$397/mo therafter' card are gone. Ongoing price quiz-gated = not published.
Unchanged — page title verbatim 'Brightmeds: Choose Your TRT Goal: $75 Per Week, Free Labs'. TRT side-effect disclosures now also cover Enclomiphene and Anastrozole (new adjunct meds).
/products verbatim: '$100 Brightmeds doctor consult fee — Prescription sent to LillyDirect® or your preferred local pharmacy — You'll pay the pharmacy directly (price may vary by pharmacy)'; vials 'Medication cost is billed separately by LillyDirect®'. Drug price not published by Brightmeds.
He & She MD
⛔ THIS ROW PREVIOUSLY DESCRIBED A "microdose" TIER THAT DOES NOT EXIST. Read live from heandshemd.com/weight-loss on 2026-08-14: the word "microdose" appears NOWHERE on the homepage or the weight-loss page. $99 is Semaglutide Injection, and its own asterisk reads "Price for purchase of 12 months supply" — a twelve-month prepay divided down, which is the LONGEST commitment the clinic sells, not the shortest. The figure was real; the product was invented. The standing month-to-month rate for injectable semaglutide is $199.
Injectable tirzepatide intro $199/mo (regular $289/mo)
What’s included
Brightmeds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
In the price
Coaching
Not stated
He & She MD
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Brightmeds
8.4/10
He & She MD
9.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Brightmeds | He & She MD |
|---|---|---|
| Starting Price | $100/mo | ✓$99/mo |
| Features | 8 features | 8 features |
| States Available | 47 | ✓50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
About Brightmeds
Compounded semaglutide opens at $189/mo, with tirzepatide at $289/mo, priced flat whatever the dose, but what renewal costs later is not published until the intake quiz is done. A single membership spans longevity peptides (sermorelin, NAD+, glutathione), TRT aimed at men, and GLP-1 weight loss. Both modalities are stocked, compounded drugs with microdosing protocols included and branded Zepbound in pens and vials, a mix rarely seen. 47 states are served.
Read our full Brightmeds review →About He & She MD
GLP-1 Platinum opens at $139/month as an introductory rate on injectables, then settles at $199. That buys expedited delivery at no cost, board-certified clinicians reachable without limit, GLP-1 coaching and progress tracking inside the app, and billing only happens if a prescription is actually written. He & She MD works nationwide with doctor-prescribed compounded semaglutide and tirzepatide, injectable or oral, a microdose option, and access under brand names to Wegovy, Ozempic and Zepbound. Every state receives shipments except Louisiana. Certification is LegitScript.
Read our full He & She MD review →Pros & Cons
Brightmeds
What we like
- Tirzepatide at $100 a month, 63% below the $267 median for the same drug and form across this register
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping, labs
- Coverage is published for 47 states
- Names 2 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- No price appears until the medical intake is complete, so the cost cannot be compared before health information is submitted
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
He & She MD
What we like
- Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication, consult, shipping, coaching
- Coverage is published for all 50 states
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
He & She MD takes it, 9.3 against 8.4, and it is especially strong on starting below a standard dose, with microdose tiers. Brightmeds is no weak second and may fit you better on knowing which pharmacy fills the vial — it names Beaker Pharmacy.
Choose Brightmeds if…
You want knowing which pharmacy fills the vial — it names Beaker Pharmacy and an opening price near $100 a month.
Choose He & She MD if…
You want starting below a standard dose, with microdose tiers and an opening price near $99 a month.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Trimi Health
Knowing which pharmacy fills the vial — it names VialsRx
From $99/mo
Get started →Strut Health
Semaglutide at $99/month, 48% under the register median
From $99/mo
Get started →Oak
Semaglutide at $119/month, 37% under the register median
From $119/mo
Get started →Brightmeds vs He & She MD: FAQ
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Brightmeds and He & She MD head-to-heads in the same category.
- Brightmeds vs Trimi Health
- Brightmeds vs Embody
- Brightmeds vs Lean Meds
- He & She MD vs NextMeds
- He & She MD vs bmiMD
- He & She MD vs CoreAge Rx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.